They used a hybrid of activity-based bottom-up cost accounting to measure nursing activity using the Therapeutic Intervention Scoring System to estimate, for example, that a day on invasive mechanical ventilation cost 33%% more than a day not ventilated.
Introduction: With a high prevalence in Intensive Care Units (ICU), the Ventilator-Associated pneumonia (VAP) has been responsible for increased mortality and morbidity rates, hospital stay, duration of mechanical ventilation (MV), costs and a set of other complications.
Overall, studies showed that improvements in sedation practice, such as the introduction of guidelines and protocols, or daily interruption of sedation, were associated with improvements in outcomes including ICU and hospital length of stay, duration of mechanical ventilation, and costs.
Similar patterns could be observed for mechanical ventilation and cost of hospitalization.
Outcomes of interest were in-hospital mortality, development of acute respiratory distress syndrome (ARDS), days on mechanical ventilation, hospital cost, and length of stay.
Outcomes measured included inhospital mortality, development of acute respiratory distress syndrome (ARDS), days on mechanical ventilation, hospital cost, and length of stay.
Limited studies report increased mortality and ICU stay, requirement for mechanical ventilation and higher costs in ventilator-associated Tracheobronchitis (TAV) in comparison to patients with ventilator-associated pneumonia (NAV).
We examined the association between insurance status and mechanical ventilation (MV), hospital costs, and hospital mortality.
Patients on mechanical ventilation caused higher costs than nonventilated patients (€946 ± 355 versus €680 ± 203; P < 0.0001).
VAP is also associated with considerable morbidity, including prolonged ICU length of stay, prolonged mechanical ventilation, and increased costs of hospitalization [ 3, 4].
